Entering text into the input field will update the search result below

Arena Pharma's etrasimod an Orphan drug in U.S. for eosinophilic esophagitis

Jun. 09, 2021 8:56 AM ETPfizer Inc. (PFE) StockPFEBy: SA News Team
  • The FDA has granted Orphan Drug Designation status to Arena Pharmaceuticals' (ARNA) etrasimod, once-daily, oral sphingosine 1-phosphate (S1P) receptor modulator, for the treatment of eosinophilic esophagitis (EoE), a chronic, allergic inflammatory disease of the esophagus.
  • Among the benefits of Orphan Drug

Recommended For You

More Trending News

About PFE Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
PFE--
Pfizer Inc.